Cost-effectiveness of hospital-based treatment compared with community treatment centres: an analysis of Korea National Health Insurance claims data

被引:0
|
作者
Lee, Jeongeun [1 ]
Lee, Donghyun [2 ]
Kwon, Ohtak [1 ]
机构
[1] Hlth Insurance Review & Assessment Serv, Seoul, South Korea
[2] Yonsei Univ, Seoul, South Korea
来源
BMJ OPEN | 2024年 / 14卷 / 07期
关键词
COVID-19; infection control; health policy;
D O I
10.1136/bmjopen-2023-079232
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We compared the cost-effectiveness of hospital-based treatment and that of community treatment centres (CTCs).Design We performed statistical analysis to compare the expenses incurred by COVID-19 patients who received hospital care with those incurred by COVID-19 patients who went to CTCs.Setting and participants A study was conducted on 411 530 COVID-19 inpatients and 243 329 CTC patients from January 2020 to December 2021.Main outcome measures We calculated the probability of severe disease, hospitalisation period and medical expenses for inpatients and CTC patients. Subsequently, we analysed the cost-effectiveness of CTC compared with hospitalisation.Results Comparing medical expenses, CTC patients incurred 2 220 000 KRW on average, which is less than the expenses incurred by hospitalised COVID-19 patients.Conclusions The study suggests that using a CTC may be more cost-effective than a hospital service alone.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Cost-effectiveness of robot-assisted lobectomy compared with VATS lobectomy for early-stage lung cancer in the National Health Insurance Program of Korea
    Lee, Hyun-Sung
    Jang, Hee-Jin
    Park, Seong Yong
    Joo, Jungnam
    Zo, Jae Ill
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [32] Immediate Compared With Deferred Treatment for Gestational Diabetes Mellitus: A Cost-Effectiveness Analysis
    Prasad, Ruhika
    Arora, Megha
    Doshi, Uma
    Caughey, Aaron B.
    OBSTETRICS AND GYNECOLOGY, 2024, 143 (5S): : 16S - 17S
  • [33] ANNUAL HEALTH INSURANCE TREATMENT COST OF FEMALE INFERTILITY ASSOCIATED WITH MALE FACTORS BASED ON REAL-WORLD HEALTH INSURANCE CLAIMS DATA
    Ponusz-Kovacs, D.
    Elmer, D.
    Csakvari, T.
    Kajos, L.
    Ponusz, R.
    Kovacs, B.
    Sebestyen, A.
    Bodis, J.
    Boncz, I
    VALUE IN HEALTH, 2022, 25 (07) : S340 - S341
  • [34] HEALTH INSURANCE TREATMENT COST OF FEMALE INFERTILITY ASSOCIATED WITH ANOVULATION BASED ON REAL-WORLD HEALTH INSURANCE CLAIMS DATA IN 2019 IN HUNGARY
    Elmer, D.
    Csakvari, T.
    Kajos, L.
    Ponusz, R.
    Ponusz-Kovacs, D.
    Kovacs, B.
    Sebestyen, A.
    Bodis, J.
    Boncz, I
    VALUE IN HEALTH, 2022, 25 (07) : S436 - S436
  • [35] TREATMENT OF RHEUMATOID ARTHRITIS PATIENTS WITH CHRONIC HEPATITIS B: ANALYSIS OF KOREAN NATIONAL HEALTH INSURANCE CLAIMS DATA
    Shin, K.
    Lee, E. B.
    Lee, E. Y.
    Song, Y. W.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 859 - 860
  • [36] Cost of Treatment for Brain Metastases Using Data From a National Health Insurance
    Crooks, Joseph
    Dominic, Oralia
    Shepard, Matthew
    Yu, Alexander
    Liang, Yun
    Karlovits, Stephen M.
    Wegner, Rodney E.
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (05)
  • [37] BIG DATA ANALYSIS OF CANCER TREATMENT IN GERMANY - MAPPING OF TREATMENT LANDSCAPE BASED ON A GERMAN STATUTORY HEALTH INSURANCE (SHI) CLAIMS DATA ANALYSIS
    May, M.
    Schellong, S.
    Bruchhausen, Y.
    Kretzschmar, A.
    Riess, H.
    VALUE IN HEALTH, 2018, 21 : S64 - S64
  • [38] Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients
    Barker, J
    Patrick, H
    Badenhorst, C
    SOUTH AFRICAN MEDICAL JOURNAL, 1998, 88 (09): : 1048 - +
  • [39] COST-EFFECTIVENESS OF RITUXIMAB AS SECOND-LINE BIOLOGICAL TREATMENT COMPARED TO REGISTRY DATA
    Kobelt, G.
    Lindgren, P.
    VALUE IN HEALTH, 2008, 11 (06) : A548 - A548
  • [40] PRIMARY TREATMENT PATTERNS AMONG GLAUCOMA PATIENTS IN KOREA FROM 2002 TO 2013 USING THE NATIONAL HEALTH INSURANCE SYSTEM CLAIMS DATA
    Choi, S.
    Park, S. M.
    Jee, D.
    VALUE IN HEALTH, 2017, 20 (09) : A810 - A811